Axsome Therapeutics (AXSM) Goodwill (2022 - 2026)

Axsome Therapeutics has reported Goodwill for 5 years, with the latest figure at $12.0 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $12.0 million, changed 0.35% from the prior year.
• Goodwill was little changed at $12.0 million in Q1 2026 per AXSM's latest filing, from $12.0 million in the prior quarter.
• Over five years, Goodwill peaked at $12.0 million in Q4 2024 and troughed at $1.7 million in Q2 2023.
• A 5-year average of $10.5 million and a median of $12.0 million in 2023 frame the typical range for Goodwill.
• The sharpest annual moves came in 2023 and 2024: Goodwill tumbled 85.44% in 2023, then jumped 592.84% in 2024.
• Over 5 years, Goodwill stood at $10.3 million in 2022, then grew by 16.39% to $12.0 million in 2023, then increased by 0.35% to $12.0 million in 2024, then fell by 0.35% to $12.0 million in 2025, then changed by 0.0% to $12.0 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $12.0 million, $12.0 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.